Ocular Therapeutix (OCUL) Change in Account Payables (2013 - 2026)

Ocular Therapeutix's Change in Account Payables history runs 14 years deep, the most recent figure standing at $3.7 million for Q1 2026.

• On a quarterly basis, Change in Account Payables rose 53028.57% year-over-year to $3.7 million in Q1 2026; TTM through Mar 2026 was $2.8 million, a 240.97% increase from a year earlier, with the FY2025 full-year figure at -$887000.0, down 178.93% from the prior year.
• Change in Account Payables climbed to $3.7 million in Q1 2026 per OCUL's latest filing, from -$1.4 million in the prior quarter.
• Across five years, Change in Account Payables topped out at $3.7 million in Q1 2026 and bottomed at -$2.4 million in Q2 2024.
• The 5-year median for Change in Account Payables is $247000.0 (2023), against an average of $145647.1.
• Across the five-year window, Change in Account Payables tumbled 1308.04% in 2025 and soared 53028.57% in 2026, its largest moves.
• Year by year, Change in Account Payables stood at -$1.1 million in 2022, then surged by 158.47% to $656000.0 in 2023, then tumbled by 82.93% to $112000.0 in 2024, then tumbled by 1308.04% to -$1.4 million in 2025, then soared by 374.87% to $3.7 million in 2026.
• Per Business Quant, the three latest OCUL Change in Account Payables figures stand at $3.7 million (Q1 2026), -$1.4 million (Q4 2025), and -$1.3 million (Q3 2025).